Reaction
Lung Operation reporting signals
As of the last recalculation, Lung Operation appears in 826 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is FLUTICASONE PROPIONATE AND SALMETEROL (PRR 27.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fluticasone Propionate And Salmeterol | 43 | 27.4 | 27.4 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 17 | 26.2 | 26.2 |
| Amikacin | 15 | 22.5 | 22.6 |
| Riociguat | 27 | 21.5 | 21.6 |
| Umeclidinium | 7 | 19.9 | 19.9 |
| Fluticasone Furoate And Vilanterol Trifenatate | 21 | 15.1 | 15.1 |
| Nintedanib | 14 | 11.4 | 11.4 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 18 | 11.2 | 11.2 |
| Macitentan | 29 | 10.9 | 10.9 |
| Ambrisentan | 40 | 8.4 | 8.4 |
| Dornase Alfa | 5 | 6.5 | 6.5 |